Ripertamab
Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL) [1].
Product Specifications
CAS Number
2249927-04-4
Product Name Alternative
SCT400
UNSPSC
12352203
Target
CD20
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ripertamab.html
Purity
99.91
Solubility
H2O
Smiles
[Ripertamab]
Molecular Weight
(144.56 kDa)
References & Citations
[1]Kaplon H, et al. Antibodies to watch in 2022. MAbs. 2022 Jan-Dec;14 (1) :2014296.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
